Classes
DEA Class; Rx
Common Brand Names; Lodosyn
- Decarboxylase Inhibitors
Description
Indications
For use with carbidopa-levodopa or with levodopa for Parkinson’s disease in patients for whom the dosage of carbidopa-levodopa combo provides less than adequate daily dosage of carbidopa, or in patients whose dosage requirement of carbidopa & levodopa necessitates separate titration of each entity
Dosage dependent upon concurrent dose of carbidopa-levodopa or levodopa & patient’s specific needs
Adverse Effects
no adverse reactions
Maximum Dosage
200 mg/day PO taking into consideration carbidopa given alone and as part of the combination product.
200 mg/day PO taking into consideration carbidopa given alone and as part of the combination product.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Carbidopa
(tablet)
- 25 mg
